Company profile
Neuronetics, Inc.
NASDAQ: STIM · Healthcare · Medical - Devices
#310 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
59CFH 45DQ 72GM 73SS 64
v0.1 · 65/100 weight · provisional
↑ filing timeliness, revenue growth (YoY) · ↓ Piotroski F, return on equity
Methodology →Revenue TTM
$151.6M
Rev growth YoY (TTM)
+69.5%
Net income (FY)
-$39.0M
Employees
658
as of 2026-08-18
Market cap
$218.2M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$149.2M$149.2M2025
Net income-$39.0M-$39.0M2025
Operating income-$31.4M-$31.4M2025
Total assets$141.6M$141.6M2025
Liabilities$115.3M$115.3M2025
Equity$22.4M$22.4M2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Clinical Services58%
Medical Device42%
By geography
Not disclosed.
The read
What is Neuronetics, Inc.’s revenue?
Neuronetics, Inc. booked $149.2M in FY2025 revenue, growing 99% year over year — faster than most Healthcare companies we track, at a -26.1% net margin.
Peers · Healthcare
Heron Therapeutics, Inc.58CAirSculpt Technologies, Inc.58CMacroGenics, Inc.54DElite Pharmaceuticals, Inc.77B+GRAIL Inc.51DCronos Group Inc.69BNeighbors
Chester →Key facts
CEODaniel L. Reuvers
SectorHealthcare
IndustryMedical - Devices
HeadquartersMalvern, PA
ExchangeNASDAQ: STIM
Employees658
IPO date2018-06-28
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.